Clinical Trial Update: Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 3]

View source ↗

Summary

Phase 3 trial of intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Immune Globulin Intravenous (IGIV) (intravenous immunoglobulin)

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 3 | Status: COMPLETED | Results posted: 2015-09-10